Mansour Hanine, Saad Aline, Azar Marina, Khoueiry Paul
Clinical Assistant Professor, Lebanese American University School of Pharmacy , Byblos, Lebanon.
Clinical Assistant Professor, Lebanese American University School of Pharmacy , Byblos, Lebanon ; Chairperson of Pharmacy Practice Department, Lebanese American University School of Pharmacy , Byblos, Lebanon.
Hosp Pharm. 2014 Nov;49(10):956-60. doi: 10.1310/hpj4910-956.
Drug-induced thrombocytopenia is a common adverse effect reported in the literature. Typically patients present with a low platelet count with signs and symptoms ranging from bruising to bleeding, and major organ damage. Penicillin-induced thrombocytopenia previously reported in the literature is explained primarily through the hapten-dependent antibody process. The goal of this report is to present a case of an amoxicillin/clavulanic acid-induced thrombocytopenia.
A 23-year-old male presented to the emergency department with bruises on his arms and legs after completing a full course of amoxicillin/clavulanic acid of 625 mg twice a day for 5 days for tonsillitis. After several tests, the patient was diagnosed with thrombocytopenia induced by amoxicillin/clavulanic acid. The patient was treated with a corticosteroids taper regimen for 3 weeks. He was discharged after 3 days of inpatient treatment with instructions to avoid physical activity for 2 weeks. Two weeks post discharge, the follow-up showed that the platelet count had increased.
Penicillin-induced thrombocytopenia has been previously reported in the inpatient setting where bleeding was observed. However, the patient in this case report presented with bruises on his arms and legs. The diagnosis was made by the process of elimination; not all possible tests were conducted. The patient was prescribed corticosteroids that are not indicated for drug-induced thrombocytopenia. The Naranjo scale showed that this is a probable adverse event of amoxicillin/clavulanic acid.
This is a unique case where amoxicillin/clavulanic acid was reported to be a probable cause of thrombocytopenia in an outpatient setting without signs of bleeding and without concomitant medications.
药物性血小板减少症是文献中报道的常见不良反应。典型的患者表现为血小板计数低,伴有从瘀伤到出血以及主要器官损伤的体征和症状。先前文献报道的青霉素诱导的血小板减少症主要通过半抗原依赖性抗体过程来解释。本报告的目的是呈现一例阿莫西林/克拉维酸诱导的血小板减少症病例。
一名23岁男性在因扁桃体炎每日两次服用625毫克阿莫西林/克拉维酸,共5天完成整个疗程后,双臂和双腿出现瘀伤,前往急诊科就诊。经过多项检查,该患者被诊断为阿莫西林/克拉维酸诱导的血小板减少症。患者接受了为期3周的皮质类固醇递减治疗方案。住院治疗3天后出院,医嘱避免体力活动2周。出院后两周的随访显示血小板计数有所增加。
先前在住院患者中曾报道过青霉素诱导的血小板减少症伴有出血情况。然而,本病例报告中的患者表现为双臂和双腿出现瘀伤。诊断是通过排除法做出的;并非进行了所有可能的检查。该患者被开具了并不适用于药物性血小板减少症的皮质类固醇。Naranjo量表显示这是阿莫西林/克拉维酸可能导致的不良事件。
这是一例独特的病例,在门诊环境中,阿莫西林/克拉维酸被报道为血小板减少症的可能病因,且无出血迹象且未同时使用其他药物。